Sustained induction of microsomal enzymes with absence of liver damage on feeding phenobarbitone or butylated hydroxytoluene
Common injection sites include the abdomen (at least two inches away from the navel), the front or side of the thighs, and the back of the upper arms
Individual variability depends partly on genetics, baseline metabolic health, and nutritional status
ARGs, hub genes of ARGs and enrichment analysis
A 2025 study discovered this bacterial enzyme pathway and even identified an inhibitor that could block it [170, 171]
The latter enrolled 190 patients with obesity (mean age 54.4 years, mean BMI 36.1 kg/m 2 ) and biopsy-proven MASH and moderate-to-severe fibrosis regardless of the presence of T2D, showing a BW reduction of 10.7%, 13.3%, 15.6% and 0.8% at 52 weeks with tirzepatide 5 mg, 10 mg, 15 mg and placebo, respectively 39